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After the industry session, the physical Competence Centre 
TEDD embedded in the Centre for Cell Biology and Tissue Engi-
neering at the ZHAW presented its core competencies, including:
- Cell biology with a focus on stem cell research, cell-based as-
says, cell differentiation, glycobiology, and cellular engineer-
ing 
- Applied matrix biology and biophysics (macromolecular 
crowding, supramolecular aggregates) to develop metabolically 
active human models such as fatty tissue and skeletal muscle 
- Establishment and analysis of tissue equivalents on scaffolds 
used in the fields of regenerative medicine and substance test-
ing 
- 3D cell culture model development that is suitable for the phar-
ma industry and personalized medicine, including technolo-
gies such as bioprinting 
Dr Markus Rimann concluded meeting with an outlook for the 
TEDD network. The goal of the network is to grow further and to 
closely collaborate with other networks and associations to inte-
grate new stakeholders from different industry sectors. 
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human fibroblasts maintained as spheroids become primed to re-
spond to small molecules. Specifically, human fibroblasts could 
be reprogramed into stem cells strongly expressing Oct4, Sox3 
and Nanog using three small molecules. The same approach was 
used to rejuvenate senescent human mesenchymal stem cells and 
fibroblasts. Senescent cells, cultured as spheroids and treated 
with a single small molecule, began to proliferate and regained 
their multipotency and differentiation efficiency into bone cells. 
These observations have important implications for pharmaceuti-
cal companies on how they should conduct cell-based screening 
for small bioactive molecules.
The afternoon session started with the keynote of Prof 
Zhongze Gu, in which he presented the activities of Southeast 
University (SEU) in China for the TEDD community similarly as 
the day before at the workshop. Then, Dr Wing Chang, director 
of research and development at STEMCELL Technologies, Cam-
bridge, UK talked about robust and efficient tools for pluripotent 
stem cell and organoid research. 
Dr Parto Toofan from REPROCELL Europe Limited, pre-
sented the company’s efforts to produce GMP-grade iPSCs for 
drug screening and translational medicine using a safe mRNA 
strategy. iPSCs produced in GMP-grade for drug screening and 
translational medicine have the potential to provide patient-spe-
cific scalable biologic material of various tissue types, useful for 
investigating the pathophysiology of rare disorders. iPSCs not 
only serve as excellent stem cell models, but they also can dif-
ferentiate into a wide variety of cell types for preclinical studies, 
providing an unlimited source for the development of healthy or 
diseased cell models in which to study the effectiveness and tox-
icity of pharmaceuticals.
tended by 26 international participants with different scientific 
backgrounds. 
Giulio Casati, director of the Lake Como School of Advanced 
Studies, opened the event by presenting the activities and the 
mission of the school. 
Francesca Caloni gave an overview on “Alternative models 
and in vitro strategy”, stressing the importance of a predictive 
interdisciplinary science for risks related to the environment, hu-
The international Virtual Summer School: Alternative Methods 
and Models in Science: A Multidisciplinary in vitro Approach1, 
targeted at PhD students and young scientists was focused on in 
vitro advanced and innovative methodologies, their application 
in different disciplines, from toxicology to microbiology, and fu-
ture perspectives. The two-day event held on June 3-4, 2020 was 
chaired by Francesca Caloni, Università degli Studi di Milano, 
Department of Environmental Science and Policy, and was at-
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man and animal health, together with the application of the 3Rs 
principle. Alternative in vitro models, either as stand-alone meth-
ods or as parts of an integrated testing strategy, as simple barrier 
models or more complex 3D cultures, were described in the con-
text of their role in risk assessment evaluation. 
Helena Kandárová, CEM & FChFT Bratislava, gave a lecture 
on “Skin irritation testing in vitro – 3D reconstructed human skin 
models”. Human skin models (RHSM) and respective in vitro 
protocols have been validated and adopted by regulatory agen-
cies as full or partial replacements of animal experiments, i.e., 
for skin corrosion and skin irritation as OECD Test Guidelines 
(TG 431 and 439) and for chemical testing (EU REACH regula-
tion). Recently, the ICH guideline S10 implemented RHSM for 
phototoxicity assessment of topically applied substances as part 
of a tiered testing strategy. RHSM are predominantly used for 
the evaluation of hazard, but they can be applied also in the risk 
assessment process if appropriate protocols and exposures are 
used. The cosmetic industry is using RHSM not only to assess 
the skin tolerance of their products but also to test the efficacy of 
novel ingredients and formulations. Most recently, RHSM were 
recognized as useful tools in the assessment of human skin irrita-
tion effects of medical devices (De Jong et al., 2018; Kandarova 
et al., 2018). Wound healing and efficacy studies conducted with 
RHSM were also discussed. 
Marisa Meloni, CEO VitroScreen, Milan, Italy, presented 
a talk entitled: “Eye irritation: an endless challenge for in vitro 
science”. The process leading to replacement of the Draize rabbit 
test with alternative non-animal approaches, such as the Integrat-
ed Approach on Testing and Assessment (IATA) for Serious Eye 
Damage and Eye Irritation (OECD, 2017), has taken almost 20 
years. The industrial need to evaluate the tolerance of ophthalmic 
formulations in a more relevant, sensitive and reproducible way 
compared with the in vivo Draize rabbit test has driven the devel-
opment of alternative approaches that better assess these products 
under realistic exposure conditions. A multiparametric approach 
(MEA) with defined acute and repeated protocols on reconstruct-
ed human corneal epithelium (HCE) has been used to assess de-
layed cytotoxicity effects of eye drops and exclude any potential 
chronic damage to the ocular surface structure. Information on the 
mechanism of action and reversibility of the damage can be ob-
tained by investigating the expression level of occludin, a func-
tional protein of the tight junctions (Meloni et al., 2010). The re-
sults confirmed the reliability, sensitivity and predictivity of the 
MEA approach on HCE in detecting subclinical signs of cellu-
lar toxicity also for so-called “soft” preservatives, suggesting the 
need to include delayed toxicity evaluation in the biocompatibili-
ty and risk assessment of ophthalmological formulations intended 
for long-term use (Meloni et al., 2019).
Arno C. Gutleb, Environmental Research and Innovation (ER-
IN) Department, Luxembourg Institute of Science and Technol-
ogy, gave a lecture entitled: “Current status of in vitro models to 
evaluate pulmonary toxicity”. Inhalation of chemicals can have a 
wide range of effects from irritation in the airways, development 
of respiratory sensitization, to systemic effects. In vitro air-liquid 
interface (ALI) cell culture models have been developed to assess 
inhalation toxicology relevant endpoints. Such models range in 
complexity from single cell lines to complex 3D models consist-
ing of several cell types. Adequate exposure techniques are es-
sential when it comes to exposing cells grown at the ALI, and an 
overview of available exposure devices was presented. ALI cul-
tures can serve as an excellent test case to show the impact of re-
placing animal-derived products, such as foetal calf serum, which 
are known to be a source of high experimental variability. The 
status of development, validation, and needs for further improve-
ments of in vitro models and their potential to replace animal ex-
periments in a regulatory context was also discussed.
Hassan Rashidi, NIHR Great Ormond Street Hospital Bio-
medical Research Centre, UCL Great Ormond Street Institute of 
Child Health, University College London, provided a short histo-
ry of 2D and 3D cell culture techniques and described the devel-
opment of a 3D platform based on hepatocytes generated from hu-
man pluripotent stem cells (hPSCs) as an in vitro tool to evaluate 
liver toxicity of new lead compounds. 2D-derived HLCs exhibit 
foetal features and transient phenotype in vitro, limiting their clin-
ical application (Cameron et al., 2015). However, novel 3D liver 
organoids are not suitable for clinical application due to their reli-
ance on animal-derived and undefined biological components. A 
novel platform was developed to generate hPSC-derived 3D hep-
atospheres (3D Heps) under xeno-free and GMP-ready conditions 
(Rashidi et al., 2018). The 3D Heps downregulated the expression 
of alpha-fetoprotein, a foetal marker, and remained metabolical-
ly active and drug-inducible for over a year in culture, providing 
an in vitro platform to evaluate long-term hepatotoxicity. Notably, 
generated 3D tissues provided critical liver support in tyrosinemia 
type-I animal models, indicating that these tissues may be able to 
treat certain liver diseases in the future.
Yula Sambuy, CREA-Research Centre for Food & Nutrition in 
Rome, Italy, introduced the most common in vitro intestinal bar-
rier models and some promising advancements in this field. The 
human intestinal Caco-2 cell line has been used for thirty years 
to study intestinal toxicology and physiology. Derived from a 
colon adenocarcinoma, it can be made to differentiate on perme-
able substrates into a monolayer of polarized cells, coupled by 
functional tight and adherence junctions and expressing several 
transport and metabolic features of the absorptive enterocytes of 
the small intestine. However, cell- and culture-dependent fac-
tors strongly affect the expression of fully differentiated features 
(Sambuy et al., 2005). Newer approaches involve co-culture mod-
els of Caco-2 with other intestinal cell types, and 3D-intestinal 
preparations from normal human tissue have become available. 
Human induced pluripotent stem cells and organoid technologies 
(Nakamura and Sato, 2018) promise to be the next step towards 
obtaining human tissue-relevant models of the intestinal mucosa.
Teresa Coccini, Laboratory of Clinical and Experimental Tox-
icology, ICS Maugeri, IRCCS Pavia, Italy, presented a talk enti-
tled “Human cell-based models for neurotoxicity”. In vitro cell-
based models for neurotoxicology research are moving on from 
simple in vitro systems with single cell types to more advanced 
models including 3D models (spheroids), cell co-cultures and 
primary human cells. Human umbilical cord lining (CL) can be 
used to isolate pluripotent mesenchymal stem cells (hCL-MSCs), 
which have strong, long-term proliferative ability (self-renewal) 
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and show stable amplification in vitro, are widely available with-
out ethical restrictions, and can be easily differentiated into spe-
cific cells. In view of the limited access to human tissue, stem 
cells are likely to gain further importance as an alternative to pri-
mary human cells. 
Doris Wilflingseder, Institute of Hygiene and Medical Mi-
crobiology, Medical University of Innsbruck, gave a talk on 
“Studying infectious diseases in animal free human 3D models”. 
3D animal-free barrier/immune cell systems were developed to 
study interactions of respiratory barriers with pathogenic fungi, 
SARS-CoV-2 or influenza or to test novel approaches against 
HIV-1 infection of a mucosal model. Confocal microscopy and 
high content screening of 3D respiratory/mucosal samples pro-
vide high-resolution pictures and enable quantitative analyses of 
a high number of cells (Zaderer et al., 2019). Culture under per-
fused conditions results in accelerated differentiation of barrier 
models (Chandorkar et al., 2019). Primary respiratory cells of the 
bronchial and small airway epithelial tract can be cultured over a 
period of more than two years without losing epithelial integrity, 
impacting mitochondrial fitness or affecting mucus production by 
goblet cells. Interactions with fluorescent beads, fungi and viruses 
can be studied in such cultures. 
An interactive debate with the participants on the perspectives 
and future role of alternative in vitro models on replacement con-
cluded the event.
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